PRQR icon

ProQR Therapeutics

56 hedge funds and large institutions have $340M invested in ProQR Therapeutics in 2019 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 17 increasing their positions, 15 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding in top 10

Funds holding in top 10:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more ownership

Funds ownership:

less first-time investments, than exits

New positions opened: | Existing positions closed:

2% less funds holding

Funds holding: 5756 (-1)

7% less capital invested

Capital invested by funds: $364M → $340M (-$24.8M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $27K

Holders
56
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
$27K
Net Calls
Net Calls Change

Top Buyers

1 +$45.4M
2 +$7.55M
3 +$6.75M
4
NAMA
Nikko Asset Management Americas
New York
+$4.02M
5
Goldman Sachs
Goldman Sachs
New York
+$1.73M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$51.8M
2
$51.6M
3
$49M
4
$40.1M
5
$27.5M
6
$19.4M
7
$13.3M
8
$10.9M
9
$10M
10
$6.93M
11
$6.87M
12
$6.75M
13
$6.43M
14
$4.02M
15
$3.63M
16
$3.63M
17
$3.47M
18
$2.76M
19
$2.63M
20
$2.56M
21
$1.92M
22
$1.57M
23
$1.56M
24
$1.14M
25
$1.09M